Godavari Drugs Limited (BOM:530317)

Market Cap	657.11M -16.1%
Revenue (ttm)	986.94M -24.2%
Net Income	36.92M -43.9%
EPS	4.91 -43.9%
Shares Out	7.53M
PE Ratio	17.77
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	559
Average Volume	6,120
Open	88.20
Previous Close	89.68
Day's Range	88.20 - 89.90
52-Week Range	69.70 - 115.00
Beta	0.17
RSI	48.66
Earnings Date	Feb 14, 2026

About Godavari Drugs

Godavari Drugs Limited manufactures and sells active pharmaceutical ingredients (APIs), drug intermediaries, and fine chemicals in India. The company offers APIs, including ciprofloxacin HCl, ciprofloxacin lactate, ciprofloxacin betaine, mefenamic acid, enrofloxacin, and elthambutoal HCI; and intermediaries, such as A D lactone for spironolactone and 6 mercaptopurine for azathioprine. It also provides loan licenses and contract manufacturing services for APIs and drug intermediates. The company serves the life science industry. Godavari Drugs L...

• Industry: Pharmaceutical Preparations
• Founded: 1987
• Employees: 106
• Stock Exchange: Bombay Stock Exchange
• Ticker Symbol: 530317

Financial Performance

In fiscal year 2025, Godavari Drugs's revenue was 1.14 billion, a decrease of -27.42% compared to the previous year's 1.57 billion. Earnings were 43.80 million, a decrease of -21.07%.